JP5571561B2 - 医薬品吸入装置及びそれらの構成要素 - Google Patents

医薬品吸入装置及びそれらの構成要素 Download PDF

Info

Publication number
JP5571561B2
JP5571561B2 JP2010533235A JP2010533235A JP5571561B2 JP 5571561 B2 JP5571561 B2 JP 5571561B2 JP 2010533235 A JP2010533235 A JP 2010533235A JP 2010533235 A JP2010533235 A JP 2010533235A JP 5571561 B2 JP5571561 B2 JP 5571561B2
Authority
JP
Japan
Prior art keywords
item
coating
group
component
metallic coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010533235A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502646A (ja
JP2011502646A5 (enExample
Inventor
エー． ジンクス，フィリップ
エム． デイビッド，モーゼス
イェー． ダムス，ルドルフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of JP2011502646A publication Critical patent/JP2011502646A/ja
Publication of JP2011502646A5 publication Critical patent/JP2011502646A5/ja
Application granted granted Critical
Publication of JP5571561B2 publication Critical patent/JP5571561B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00—Processes for applying liquids or other fluent materials
    • B05D1/62—Plasma-deposition of organic layers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D5/00—Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures
    • B05D5/08—Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface
    • B05D5/083—Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface involving the use of fluoropolymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D5/00—Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures
    • B05D5/08—Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface
    • B05D5/083—Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface involving the use of fluoropolymers
    • B05D5/086—Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface involving the use of fluoropolymers having an anchoring layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/44—Valves specially adapted for the discharge of contents; Regulating devices
    • B65D83/52—Metering valves; Metering devices
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/02—Pretreatment of the material to be coated
    • C23C16/0227—Pretreatment of the material to be coated by cleaning or etching
    • C23C16/0245—Pretreatment of the material to be coated by cleaning or etching by etching with a plasma
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/26—Deposition of carbon only
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/30—Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/30—Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
    • C23C16/40—Oxides
    • C23C16/401—Oxides containing silicon
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/56—After-treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D2202/00—Metallic substrate
    • B05D2202/10—Metallic substrate based on Fe
    • B05D2202/15—Stainless steel
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/26—Web or sheet containing structurally defined element or component, the element or component having a specified physical dimension
    • Y10T428/263—Coating layer not in excess of 5 mils thick or equivalent
    • Y10T428/264—Up to 3 mils
    • Y10T428/265—1 mil or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31652—Of asbestos
    • Y10T428/31663—As siloxane, silicone or silane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31652—Of asbestos
    • Y10T428/31667—Next to addition polymer from unsaturated monomers, or aldehyde or ketone condensation product

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Organic Chemistry (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Plasma & Fusion (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Chemical Vapour Deposition (AREA)
JP2010533235A 2007-11-06 2008-11-06 医薬品吸入装置及びそれらの構成要素 Expired - Fee Related JP5571561B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98574107P 2007-11-06 2007-11-06
US60/985,741 2007-11-06
PCT/US2008/082600 WO2009061895A2 (en) 2007-11-06 2008-11-06 Medicinal inhalation devices and components thereof

Publications (3)

Publication Number Publication Date
JP2011502646A JP2011502646A (ja) 2011-01-27
JP2011502646A5 JP2011502646A5 (enExample) 2011-12-22
JP5571561B2 true JP5571561B2 (ja) 2014-08-13

Family

ID=40626431

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010533235A Expired - Fee Related JP5571561B2 (ja) 2007-11-06 2008-11-06 医薬品吸入装置及びそれらの構成要素
JP2010533232A Expired - Fee Related JP5571560B2 (ja) 2007-11-06 2008-11-06 医薬品吸入装置及びそれらの構成要素

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010533232A Expired - Fee Related JP5571560B2 (ja) 2007-11-06 2008-11-06 医薬品吸入装置及びそれらの構成要素

Country Status (8)

Country Link
US (3) US8430097B2 (enExample)
EP (2) EP2205303B1 (enExample)
JP (2) JP5571561B2 (enExample)
CN (2) CN101909682B (enExample)
AU (2) AU2008323920B2 (enExample)
BR (2) BRPI0817384A2 (enExample)
CA (2) CA2704997C (enExample)
WO (2) WO2009061891A2 (enExample)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
JP4681231B2 (ja) 2002-03-20 2011-05-11 マンカインド コーポレイション 吸入装置
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
CN104383546B (zh) 2006-02-22 2021-03-02 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
JP4884180B2 (ja) * 2006-11-21 2012-02-29 東京エレクトロン株式会社 基板処理装置および基板処理方法
GB0721737D0 (en) * 2007-11-06 2007-12-19 3M Innovative Properties Co Medicinal inhalation devices and components thereof
WO2009061891A2 (en) * 2007-11-06 2009-05-14 3M Innovative Properties Company Medicinal inhalation devices and components thereof
EP2534957B1 (en) 2007-12-14 2015-05-27 AeroDesigns, Inc Delivering aerosolizable products
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
MY155524A (en) 2008-06-13 2015-10-30 Mannkind Corp A dry powder inhaler and system for drug delivery
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
CA2760801A1 (en) 2009-05-06 2010-11-11 3M Innovative Properties Company Medicinal inhalation device
AU2010245839B2 (en) * 2009-05-06 2014-01-16 3M Innovative Properties Company Medicinal inhalation devices and components thereof
EP2427902B1 (en) 2009-05-06 2017-01-18 3M Innovative Properties Company Apparatus and method for plasma treatment of containers
AU2010259943C1 (en) 2009-06-12 2016-03-03 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
GB201003275D0 (en) * 2010-02-26 2010-04-14 Portal Medical Ltd Method of manufacturing a medicament dispenser device
GB201003273D0 (en) * 2010-02-26 2010-04-14 Portal Medical Ltd Medicament dispenser device
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
GB201016797D0 (en) * 2010-10-06 2010-11-17 British American Tobacco Co Aerosol generator
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
US9572596B2 (en) * 2011-06-30 2017-02-21 Covidien Lp Applicators for controlled in situ delivery of therapeutic compositions and implants, methods of fabrication and use
HK1201475A1 (en) 2011-10-24 2015-09-04 Mannkind Corporation Methods and compositions for treating pain
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
DE102012110131A1 (de) * 2012-10-24 2014-04-24 Schott Ag Verbundmaterial für ein pharmazeutisches Packmittel, Verfahren zu dessen Herstellung und Verwendung des Verbundmaterials
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
GB201221063D0 (en) * 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
BR112015023168B1 (pt) 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
JP6279222B2 (ja) * 2013-03-25 2018-02-14 スリーエム イノベイティブ プロパティズ カンパニー 摩擦係数の低い表面を有するポリマーを含む物品及びその製造方法
FR3006300B1 (fr) * 2013-06-04 2015-07-03 Aptar France Sas Valve doseuse et dispositif de distribution de produit fluide comportant une telle valve.
EP3013526A4 (en) 2013-06-24 2017-03-08 3M Innovative Properties Company Abrasive particles, method of making abrasive particles, and abrasive articles
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
US8962449B1 (en) * 2013-07-30 2015-02-24 Micron Technology, Inc. Methods for processing semiconductor devices
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
PL3104853T3 (pl) * 2014-02-10 2020-05-18 Respivant Sciences Gmbh Leczenie stabilizatorami komórek tucznych zaburzeń ogólnoustrojowych
JP2017505348A (ja) 2014-02-10 2017-02-16 パタラ ファーマ リミテッド ライアビリティ カンパニー 肺疾患治療のための肥満細胞安定剤
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
EP3146000B1 (en) 2014-05-22 2019-06-26 3M Innovative Properties Company Coating process
GB2536285A (en) * 2015-03-13 2016-09-14 3M Innovative Properties Co Coating process
US20170189329A1 (en) 2014-07-29 2017-07-06 3M Innovative Properties Company Method of preparing a pharmaceutical composition
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
WO2017027387A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of mast cell related disorders with mast cell stabilizers
EP3341059B1 (en) 2015-09-10 2022-03-02 Impel NeuroPharma Inc. In-line nasal delivery device
EP3368083A1 (en) 2015-10-29 2018-09-05 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
US9834713B2 (en) 2016-02-23 2017-12-05 3M Innovative Properties Company Oriented thermally conductive dielectric film
JP2019528320A (ja) 2016-08-31 2019-10-10 レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ 特発性肺線維症による慢性咳の治療のためのクロモリン組成物
EP3522983A4 (en) 2016-10-07 2020-06-03 Respivant Sciences GmbH CROMOLYN COMPOSITION FOR TREATING LUNG FIBROSIS
WO2018213244A1 (en) 2017-05-17 2018-11-22 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
EP3661577B1 (en) 2017-08-03 2023-03-01 Kindeva Drug Delivery L.P. Coating process
BR112020013744A8 (pt) 2018-01-05 2022-10-18 Impel Neuropharma Inc Dispensação intranasal de di-hidroergotamina por dispositivo olfativo de precisão
CN112203641A (zh) 2018-06-07 2021-01-08 金德瓦药物控释有限公司 氟替卡松和维兰特罗制剂以及吸入器
WO2019236649A1 (en) 2018-06-07 2019-12-12 3M Innovative Properties Company Fluticasone and vilanterol formulation and inhaler
WO2020006017A1 (en) * 2018-06-27 2020-01-02 3M Innovative Properties Company Tiotropium formulation and inhaler
WO2020100040A1 (en) 2018-11-12 2020-05-22 3M Innovative Properties Company Umeclidinium and vilanterol formulation and inhaler
EP3756711A1 (en) * 2019-06-25 2020-12-30 Presspart Gmbh & Co. Kg Method of plasma cleaning and coating of mdi cans
GB202011729D0 (en) * 2020-07-29 2020-09-09 Kindeva Drug Delivery Lp Device for delivery of a compound to a region of the nasal cavity
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US12029562B2 (en) 2021-04-14 2024-07-09 Satio, Inc. Dermal patch system
WO2023039103A1 (en) 2021-09-08 2023-03-16 Kindeva Drug Delivery L.P. Metered dose inhalers and suspension compositions
JP2026509779A (ja) 2022-03-01 2026-03-25 キンデーバ ドラッグ デリバリー リミティド パートナーシップ 定量吸入器及び高用量懸濁液
EP4673113A1 (en) 2023-03-02 2026-01-07 Kindeva Drug Delivery L.P. Metered dose inhalers and solutions including cannabinoids in hfo-1234ze(e)
JP2026507199A (ja) 2023-03-02 2026-02-27 キンデーバ ドラッグ デリバリー リミティド パートナーシップ 定量吸入器及びｈｆａ－１５２ａ中にカンナビノイドを含む溶液
GB202416564D0 (en) 2024-11-11 2024-12-25 Portal Medical Ltd Medicament dispenser device
WO2026136361A2 (en) 2024-12-17 2026-06-25 Kindeva Drug Delivery L.P. Metered dose inhalers and suspension compositions including polyethylene glycol

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3810874A (en) 1969-03-10 1974-05-14 Minnesota Mining & Mfg Polymers prepared from poly(perfluoro-alkylene oxide) compounds
DE3832692A1 (de) 1988-09-27 1990-03-29 Leybold Ag Dichtungselement mit einem absperrkoerper aus einem metallischen oder nichtmetallischen werkstoff und verfahren zum auftragen von hartstoffschichten auf den absperrkoerper
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
JPH11501892A (ja) 1995-03-10 1999-02-16 ミネソタ マイニング アンド マニュファクチャリング カンパニー エアロゾルバルブ
MX9707862A (es) 1995-04-14 1997-11-29 Glaxo Wellcome Inc Inhalador de dosis medida para el propionato de fluticasona.
DE69622166T2 (de) 1995-04-14 2003-04-03 Smithkline Beecham Corp., Philadelphia Dosierinhalator für albuterol
CA2218179A1 (en) 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Metered dose inhaler for beclomethasone dipropionate
EP1366777B1 (en) 1995-04-14 2005-06-15 SmithKline Beecham Corporation Metered dose inhaler for salmeterol
ATE211510T1 (de) 1997-02-04 2002-01-15 Bekaert Sa Nv Beschichtung enthaltend filme aus diamantartigem kohlenstoff und diamantartigem nanokomposit
GB2329939A (en) 1997-06-26 1999-04-07 Glaxo Group Ltd Self-lubricating valve stem for aerosol containers
US20030103906A1 (en) 1997-10-14 2003-06-05 Smithkline Beecham Corporation Metered dose inhaler having internal surfaces coated with fluorocarbon polymer
CN1168510C (zh) 1998-02-23 2004-09-29 葛兰素集团有限公司 药物配送装置
DE1005917T1 (de) * 1998-12-01 2001-01-11 Microflow Engineering S.A., Neuenburg/Neuchatel Inhalator mit Ultraschallzerstäuber dessen Sprühöffnungen den Maximalamplituden eines stehenden Wellenmusters überlagert sind
DE19958336A1 (de) 1999-12-03 2001-06-07 Inst Neue Mat Gemein Gmbh Selbstvernetzende Beschichtungszusammensetzungen auf Basis anorganischer fluorhaltiger Polykondensate
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
WO2001064275A1 (en) 2000-03-01 2001-09-07 Glaxo Group Limited Metered dose inhaler
EP1259276A2 (en) 2000-03-01 2002-11-27 Glaxo Group Limited Metered dose inhaler
US20030145850A1 (en) 2000-03-01 2003-08-07 Hailey Mark Andrew Metered dose inhaler
EP1259429A2 (en) 2000-03-01 2002-11-27 Glaxo Group Limited Metered dose inhaler
US6696157B1 (en) * 2000-03-05 2004-02-24 3M Innovative Properties Company Diamond-like glass thin films
WO2002009791A1 (en) 2000-07-28 2002-02-07 Blue Medical Devices B.V. Intravascular stent with expandable coating
GB0025092D0 (en) 2000-10-13 2000-11-29 Glaxo Group Ltd Medicament dispenser
SE0004610D0 (sv) * 2000-12-13 2000-12-13 Astrazeneca Ab Surface modification process
NZ526564A (en) * 2000-12-22 2004-12-24 Glaxo Group Ltd Metered dose inhaler for salmeterol xinafoate
WO2002100928A1 (en) * 2001-06-12 2002-12-19 North Carolina State University Barrier coatings for elastomeric materials
CA2449433A1 (en) * 2001-06-20 2003-01-03 Microvention, Inc. Medical devices having full or partial polymer coatings and their methods of manufacture
US20030031806A1 (en) 2001-07-10 2003-02-13 Jinks Philip A. Medicinal inhalation devices and components coated using thermal chemical vapor deposition
GB0122725D0 (en) 2001-09-21 2001-11-14 Glaxo Group Ltd Drug dispensing components
US6649272B2 (en) 2001-11-08 2003-11-18 3M Innovative Properties Company Coating composition comprising fluorochemical polyether silane polycondensate and use thereof
US6716534B2 (en) 2001-11-08 2004-04-06 3M Innovative Properties Company Coating composition comprising a fluorochemical polyether silane partial condensate and use thereof
AU2002357789A1 (en) * 2001-12-07 2003-06-23 Glaxo Group Limited Metering valve and pharmaceutical metered dose inhaler and methods thereof
US6878419B2 (en) 2001-12-14 2005-04-12 3M Innovative Properties Co. Plasma treatment of porous materials
SE0200313D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel process
US20050133025A1 (en) 2002-05-14 2005-06-23 Juha Laiho Inhalator and method of manufacturing same
WO2004022142A1 (en) 2002-09-06 2004-03-18 3M Innovative Properties Company Metering valve for a metered dose inhaler providing consistent delivery
US20040223916A1 (en) 2003-02-20 2004-11-11 Burt Peter Colin Weston Canister for a metered dose inhaler
US7758936B2 (en) 2003-09-18 2010-07-20 Boehringer Ingelheim Gmbh Pharmaceutical blister
GB0328502D0 (en) * 2003-12-10 2004-01-14 3M Innovative Properties Co Metered dose dispensers and assemblies therefor
JP5385146B2 (ja) 2006-10-20 2014-01-08 スリーエム イノベイティブ プロパティズ カンパニー 易洗浄基材のための方法及びそれによる物品
WO2009061891A2 (en) * 2007-11-06 2009-05-14 3M Innovative Properties Company Medicinal inhalation devices and components thereof
GB0721737D0 (en) * 2007-11-06 2007-12-19 3M Innovative Properties Co Medicinal inhalation devices and components thereof
GB0721739D0 (en) * 2007-11-06 2007-12-19 3M Innovative Properties Co medicinal inhalation devices and components thereof
CA2760801A1 (en) * 2009-05-06 2010-11-11 3M Innovative Properties Company Medicinal inhalation device

Also Published As

Publication number Publication date
CA2704985C (en) 2017-02-28
EP2205303B1 (en) 2013-11-06
CN101909684A (zh) 2010-12-08
WO2009061895A2 (en) 2009-05-14
US20130213395A1 (en) 2013-08-22
JP2011502645A (ja) 2011-01-27
BRPI0817384A2 (pt) 2015-03-31
CN101909682A (zh) 2010-12-08
EP2205302A4 (en) 2010-12-29
JP5571560B2 (ja) 2014-08-13
AU2008323920A1 (en) 2009-05-14
CN101909684B (zh) 2014-03-19
WO2009061891A3 (en) 2009-07-02
EP2205302A2 (en) 2010-07-14
AU2008323924B2 (en) 2013-01-17
US20100242958A1 (en) 2010-09-30
CN101909682B (zh) 2013-09-18
EP2205303A2 (en) 2010-07-14
WO2009061891A2 (en) 2009-05-14
US8808786B2 (en) 2014-08-19
CA2704997A1 (en) 2009-05-14
JP2011502646A (ja) 2011-01-27
CA2704985A1 (en) 2009-05-14
US8414956B2 (en) 2013-04-09
CA2704997C (en) 2016-05-24
US8430097B2 (en) 2013-04-30
BRPI0817398A2 (pt) 2015-04-07
US20100247932A1 (en) 2010-09-30
AU2008323920B2 (en) 2012-12-20
WO2009061895A3 (en) 2009-07-16
EP2205303A4 (en) 2012-03-14
AU2008323924A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
JP5571560B2 (ja) 医薬品吸入装置及びそれらの構成要素
US8815325B2 (en) Medicinal inhalation device
EP2205300B1 (en) Medicinal inhalation devices and components thereof
EP2427278B1 (en) Medicinal inhalation devices and components thereof
US8616201B2 (en) Medicinal inhalation devices and components thereof
AU2010245834B2 (en) Medicinal inhalation device

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111104

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20111104

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130917

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131216

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131224

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140317

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140527

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140626

R150 Certificate of patent or registration of utility model

Ref document number: 5571561

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees